Overall Objective:

1. Describe and use the current reporting and evaluation system for donor derived disease in the U.S.
2. Discuss the definition and implications of the donors with increased risk for transmission of HIV/HBV/HCV
3. Assess the safety in the use of infected donors and donors with suspected infections

Faculty/Planning Committee:

Catherine M Klapperich, MD, Speaker
Andrew Henderson, PHD, Course Director

Sabrina Assoumou, MD, Planning Committee

Robert Rosen, MD, Planning Committee

Alisa Flaherty, Administrative Coordinator

Sakina Flint, Program Manager, Continuing Medical Education

Disclosure Policy:
Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.